WhiteLab Genomics
Camille Alliot is a structural biologist with extensive experience in the biopharmaceutical sector. Currently serving as a structural biologist at WhiteLab Genomics since September 2022, Camille previously held the position of VP of BioPharma at ArcaScience from September 2021 to September 2022. At ArcaScience, a company specializing in AI tools for biomedical data, Camille contributed to projects related to drug repurposing, biomarker identification, and COVID-19 adverse event tracking. Camille obtained a Master's degree in Bioinformatics and In Silico Drug Design from Université Paris Cité and a Bachelor's degree in Biochemistry and Cell Biology from CY Cergy Paris Université. Early education includes a Scientific Baccalaureate from Lycée Louis de Broglie.
This person is not in any offices
WhiteLab Genomics
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload andvector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.